All Industries

Medicus Pharma CEO Dr. Raza Bokhari Announces Updated Phase 2 Clinical Protocol Submission to FDA

Medicus Pharma

Dr. Raza Bokhari, Executive Chairman and CEO of Medicus Pharma joined Steve Darling from Proactive to announce the submission of a comprehensive and updated Phase 2 Investigational New Drug clinical protocol to the United States Food and Drug Administration (FDA). This protocol aims to non-invasively treat basal cell carcinoma of the skin using micro-needle arrays containing doxorubicin, developed by Medicus Pharma’s wholly owned portfolio company, Skinject, Inc. The submission features significant updates to the clinical protocol, including enhancements to the supporting Chemistry, Manufacturing, and Controls (CMC), along with detailed stability and sterility information. Furthermore, it addresses the clinical non-hold comments previously received from the FDA, ensuring a robust and thorough response to regulatory feedback. Dr. Bokhari shared with Proactive that the revised Phase 2 clinical protocol incorporates innovative elements such as artificial intelligence and confocal microscopy as supplementary endpoints at one of the clinical sites. These advanced technologies are expected to provide deeper insights and improved accuracy in the clinical outcomes. Medicus Pharma believes that this updated protocol is well-positioned to receive FDA approval, paving the way for the commencement of participant randomization potentially before the end of this quarter. This milestone underscores the company’s commitment to advancing innovative treatments for skin cancer and improving patient outcomes through cutting-edge technology and rigorous clinical research. Contact Details Proactive North America +1 604-688-8158 NA-editorial@proactiveinvestors.com

July 16, 2024 11:51 AM Eastern Daylight Time

Video

Standard Fleet and UP.FIT Partner to Modernize Government Electric Vehicle Fleet Management

Standard Fleet

Standard Fleet, an electric vehicle management technology developer, and UP.FIT, an Unplugged Performance company focused on the upfitting of Tesla electric vehicles for fleet use, today announced a collaborative initiative designed to enhance government electric vehicle (EV) fleet management. This effort brings together UP.FIT’s industry-leading expertise in customizing Teslas for specialty use with Standard Fleet's sophisticated fleet management software, aims to improve operational efficiency and support the environmental goals of government fleets including those managed by emergency responders and law enforcement. “Our collaboration with UP.FIT aims to equip police departments with the tools they need for a smoother, more cost-effective fleet management experience,” said David Hodge, Founder and CEO of Standard Fleet. “Integrating our software with UP.FIT’s customized Tesla vehicles means we can offer a system that improves operational efficiency while supporting environmental goals.” "Our mission at UP.FIT is to simplify the adoption of electric fleets for first responders and fleet operators globally,” said James Hedland, Fleet Director at UP.FIT. “Standard Fleet software gives operators complete control of the access, charging, maintenance, and dispatching of their up-fitted EVs. Together we’re providing police departments and other city and county fleet operators with an electric vehicle management system proven to enhance performance and operational efficiency." The partnership addresses a growing need for cost-effective and responsible deployment of EV fleets in public service by merging the expertise and capabilities of UP.FIT and Standard Fleet. This initiative is poised to redefine fleet management for government entities, enhancing both vehicle functionality and operational oversight. Key Benefits of the Partnership: Improved Operational Efficiency: Standard Fleet’s software streamlines the management of charging, maintenance, and daily operations of EVs, reducing both time and costs for fleet managers. Tailored Vehicle Customizations: UP.FIT modifies Tesla vehicles to meet the specific needs of police and public safety operations, enhancing their reliability and suitability for work in the communities they serve. Environmental Impact: The shift towards EVs helps reduce emissions and air pollution, and aligns with local, state, and federal environmental objectives. Sergeant Tony Abdalla from the South Pasadena Police Department, a client benefiting from this partnership, stated, “Adopting electric vehicles for police work presents a unique set of challenges along with opportunities to better serve our community with a cleaner, more reliable, and higher performance police fleet at lower costs over the long term. Standard Fleet technology gives us mobile access to all of our EVs to enhance our operations from dispatch, charging, maintenance, and analytics, to keyless access for officers coming on- and off-duty. Combining Standard Fleet software with the hardware and digital technology upgrades installed by UP.FIT puts our fleet at the forefront of sustainability and performance.” This initiative underscores the potential of technology to improve public sector operations and promotes the adoption of sustainable practices in fleet management. As police departments and other city and county fleet operators increasingly turn to electric vehicles, Standard Fleet and UP.FIT provides scalable, impactful, and effective solutions for the challenges of modern fleet operations. To learn more about this strategic collaboration, please visit here. Useful Links: Learn More: www.standardfleet.com About UP.FIT: https://up.fit/ Follow us: Blog | X | Instagram | LinkedIn Sales and Partnership Inquiries: Please email Standard Fleet at contact@standardfleet.com. About Standard Fleet: Founded in 2021 and based in San Francisco, Standard Fleet envisions a future where electric vehicle (EV) fleets are at the forefront of sustainable transportation, supporting a more environmentally friendly approach to urban mobility. The company’s software simplifies the management of electric vehicle fleets by enhancing operational efficiency and facilitating the transition to sustainable transportation. For more information, please visit www.standardfleet.com. About UP.FIT: Based in Hawthorne, CA, UP.FIT, an Unplugged Performance company, is the global leader in upfitting Teslas for fleet use. Launched in response to the growing need for advanced, sustainable fleet solutions, UP.FIT collaborates with industry leaders to engineer high-level components, turnkey vehicles, training, and innovative management tools. The UP.FIT mission is to provide first responders with the most innovative, safe and reliable equipment possible, all while driving to a cleaner tomorrow. Contact Details ANW Networks for Standard Fleet Alicia V. Nieva-Woodgate +1 720-808-0086 alicia@anwnetworks.com Company Website https://www.standardfleet.com/

July 16, 2024 11:30 AM Eastern Daylight Time

Image

Nextech3D.ai Welcomes Mady Wynsma as New Head of Global Sales

Nextech3D.AI

Nextech3D.ai CEO Evan Gappelberg and new Head of Sales Mady Wynsma joined Steve Darling from Proactive to share the exciting news. Wynsma brings a wealth of experience to her new role, having worked with e-commerce giants like Walmart and Kohls. Gappelberg highlighted Wynsma's deep understanding of e-commerce and her extensive experience in building efficient, scalable, and profitable sales teams. He expressed confidence that her expertise will significantly contribute to Nextech3D.ai's growth during this pivotal time for both the company and the 3D/AI industry. Wynsma expressed her enthusiasm for joining Nextech3D.ai, emphasizing her excitement about the opportunities ahead in the rapidly evolving 3D/AI sector. She is eager to leverage her skills and experience to drive Nextech3D.ai's growth and success in this dynamic industry. Nextech3D.ai is looking forward to the innovative strategies and leadership Wynsma will bring to the team, positioning the company for continued advancement and expansion in the 3D and AI markets. Contact Details Proactive United States +1 347-449-0879 action@proactiveinvestors.com

July 16, 2024 11:15 AM Eastern Daylight Time

Video

NIA Appoints Carlos Ballesteros as Chief Financial Officer (CFO) and Treasurer

Nonprofits Insurance Alliance

Nonprofits Insurance Alliance (NIA), the nation’s leading insurer exclusively focused on the 501(c)(3) nonprofit sector, announced today that it has named Carlos Ballesteros as Chief Financial Officer (CFO) and Treasurer. Pamela Davis, NIA Founder, President, and CEO, expressed enthusiastically that, “Carlos has the perfect blend of tactical and strategic experience and skills to provide the financial leadership our growing organizations need. We conducted an extensive search to find someone with his particular qualities and are delighted he has chosen to apply his many talents to the nonprofit sector.” Mr. Ballesteros is a Certified Public Accountant and accomplished executive, with a proven track record of nearly 20 years of technical, operational, and strategic finance experience. Prior to joining the NIA Senior Leadership team, Mr. Ballesteros spent 10 years at Green Dot Corporation in many finance roles that culminated as the Vice President of Finance, where he led the financial planning and analysis team and spearheaded numerous company initiatives. Before leading finance organizations, Mr. Ballesteros spent nine years at Ernst & Young LLP in the audit practice, where he led local and multinational teams as a Senior Manager primarily within the real estate, hospitality, and construction sectors. “I am thrilled to join the Senior Leadership team at Nonprofits Insurance Alliance,” said Mr. Ballesteros. “It’s an honor to join a company with a mission of serving nonprofits, impacting the communities in which they operate. The tremendous growth the company has recently experienced is exciting and I am eager to leverage my finance expertise to drive strategic initiatives that position the company for continued success.” About NIA Nonprofits Insurance Alliance (NIA) is the nation’s leading liability and property insurer exclusively serving nonprofit organizations. Founded in 1989 in Santa Cruz, CA, NIA is a social enterprise focused on the long-term sustainability and management of risk in the nonprofit sector. NIA has one of the best customer retention rates in the industry. NIA members enjoy fair and equitable insurance pricing, specialized insurance coverages, dividends, and innovative risk management and member resources. The NIA group brand is comprised of Alliance Member Services (AMS) and three insurers rated A (Excellent) by AM Best: • Nonprofits Insurance Alliance of California (NIAC) • Alliance of Nonprofits for Insurance, RRG (ANI) • National Alliance of Nonprofits for Insurance (NANI) All organizations under the NIA brand are 501(c)(3) nonprofits. Learn more about Nonprofits Insurance Alliance at insurancefornonprofits.org Contact Details NIA Marketing & Communications editor@insurancefornonprofits.org Company Website https://insurancefornonprofits.org

July 16, 2024 08:00 AM Pacific Daylight Time

University Compounding Pharmacy Announces Rebrand to MediVera Compounding Pharmacy™

MediVera

University Compounding Pharmacy, a leader in personalized medicine since 1999, today announced it is rebranding as MediVera Compounding Pharmacy™. The rebrand comes at a time when the company is growing strongly due to the introduction of new product offerings, nationwide expansion, and the successful differentiation of its quality products and services. Despite the name change, the company’s ownership and passionate team remain the same, ensuring continuity in the high-level service and exceptional care that healthcare providers and patients have relied on for more than two decades. Over the past few years, the company has seen its revenue grow substantially. New product offerings, nationwide expansion, and strong market positioning through differentiated quality products and services, such as the Impressed Advantage program, have enabled the company to double its revenue from 2022 to 2023. Growth is anticipated to accelerate this year, with the company expecting to double revenue year-over-year once again. “Differentiation is and will continue to be an important growth driver for our company. With the Impressed Advantage customer service program, we are making the prescription process easier, faster, and more convenient for both doctors and their patients,” said Bradley McCloskey, PharmD, CEO. “As we continue to launch more product offerings and expand into more states within the next few months, 2024 is poised to become a year of strong growth as we expand our footprint into 14 additional states.” For more information about MediVera Compounding Pharmacy and its services, please visit mediverarx.com or contact Laurie Malseed, Marketing Specialist, at laurie@mediverarx.com or 937-242-0430. About MediVera Since its inception in 1999, MediVera Compounding Pharmacy™ (formerly University Compounding Pharmacy) has been dedicated to providing personalized medicine. With a focus on quality and innovation, MediVera Compounding Pharmacy™ continues to set industry standards, offering tailored solutions to meet the unique needs of healthcare providers and patients. MediVera Compounding Pharmacy™ is currently licensed in and ships to the following 33 states: AZ, CN, CO, DE, FL, GA, IA, ID, IL, IN, KY, MA, MD, ME, MI, MN, MO, MT, NC, NH, NJ, NY, OH, PA, RI, SC, SD, TN, VA, VT, WA, WI, WY. Contact Details MediVera Compounding Pharmacy Laurie Malseed +1 937-242-0430 laurie@mediverarx.com

July 16, 2024 09:00 AM Eastern Daylight Time

Cboe VP Shares His View On The Power Of Defined Outcome ETFs

Benzinga

By Johnny Rice, Benzinga Rob Marrocco, VP and Global Head of ETF Listings for Cboe Global Markets Inc. (BATS: CBOE), was recently interviewed by Benzinga. Cboe Global Markets is a leading provider of market infrastructure – operating in 26 markets globally – and facilitates trading in options, futures, equities, FX, digital assets and more for retail investors. The company has long been an innovator in financial products. Mr. Marrocco spoke about the rise of defined-outcome ETFs, which offer access to advanced trading strategies to a wide retail audience. Watch the full interview here: https://youtu.be/RjCa8RXB8jI Featured photo by rc.xyz NFT gallery on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

July 16, 2024 08:45 AM Eastern Daylight Time

Video Image

What Is Margin Trading, And Should You Try It?

Benzinga

By Gerelyn Terzo, Benzinga The stock market has come a long way from the days of open pits when buyers and sellers relied solely on facial expressions and hand signals to set prices and trade securities. Advancements in technology and the advent of electronic trading have made it possible for anyone to trade securities and harness some of the strategies that were once reserved for the elite. As investing has evolved over the centuries, so too have the possibilities traders have at their fingertips. Margin trading is one of those opportunities. It’s a game-changer for savvy investors looking for ways to increase their buying power and potentially amplify returns. With margin trading, the stakes, skill set and thrill are all higher. But so are the risks and potential rewards. Surprisingly, even many margin traders lack the key fundamentals of margin trading, according to a white paper published in 2018. Below, we explore some of the basics. Margin Trading In A Nutshell It’s been said it takes money to make money. But margin trading offers retail investors a different tack - a chance to purchase securities with borrowed funds. It’s a tactic implemented by sophisticated traders but is no longer limited only to them. Margin trading lets investors buy stocks or exchange-traded funds (ETFs) with a broker’s money, borrowed funds referred to as leverage. It’s a type of short-term financing that can give you access to more securities fast. However, investors must have skin in the game, too, which is why cash or equities in their accounts serve as collateral for trades. There are many benefits to using leverage. It allows you to trade in a more purposeful way, bolstering your buying power simultaneously. Purchase more securities and pursue multiple opportunities with freed-up capital. And you won’t have to skip market opportunities while waiting to put money to work. The key thing to remember is that when trading on margin, both your returns and losses are amplified. When successful, margin trading brings higher profits and can take your portfolio to a new level. But if a margin trade goes south, you’re on the hook for the loan amount plus interest. Additionally, as equity in your account is depleted, brokers could make a margin call. This would require you to add more funds to continue trading and is something to be prepared for. It’s vital to perform your own due diligence on potential trades while also keeping a close eye on the markets. If there are changes to market conditions or the asset, nimbly adjust your strategy before it’s too late. Like most investment strategies, there are both pros and cons to margin trading. These include: Pros: Increase buying power with borrowed funds Seize market opportunities that you would otherwise miss out on Potentially generate higher profits Cons: Risk of losing more than you would in a regular market trade Interest is charged on loans Risk of a margin call How To Participate To trade on margin, the first thing you’ll need is a margin account instead of a standard brokerage account. This account lets a broker lend you money to purchase more securities than you’d be able to do with your balance. You must be approved for a margin account. Expect to answer questions about your finances, investment experience, risk profile and goals. Next, you must meet a minimum deposit threshold. This amount will influence how much you can borrow from the broker and eventually trade. Equities and cash in your account serve as collateral to secure the loan. Brokers also charge interest on the loan that must also be repaid. As a result, you’ll want to ensure the anticipated returns will offset any interest that must be paid on the loan. Axos Invest Makes It Easy and Safe to Borrow Now that you know how margin trading works, you’ll need to choose a platform on which to trade. Look for a trusted partner to help you gain the skills to confidently navigate the markets, like Axos Invest. Axos Invest has been around since 1999 and was an early mover in the online banking movement. With more than two decades of operating history, Axos has established its staying power, so you won’t have to lose sleep about placing your hard-earned money in the wrong hands. Even if you’re new to margin trading, Axos has resources to support and educate you on the path to independent investing so you can make your portfolio work for you. Axos makes it easy to borrow against your portfolio assets, with rates as low as 7% and transparent pricing. The more you borrow, the lower your rates will be. As such, you can comfortably borrow more to build your portfolio. Opening an Axos Invest margin account opens up a world of possibilities, allowing you to make bigger stock or ETF investments without having to liquidate capital. As a result, you will gain greater market exposure and portfolio diversification while increasing your potential returns. Explore Axos Invest’s resources so you can borrow, trade and put the power of your portfolio to work. Get started with margin trading today. Featured photo by sergeitokmakov on Poxabay. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

July 16, 2024 08:30 AM Eastern Daylight Time

Image

Huma completes Series D with total financing of over $80m as it launches Huma Cloud Platform with GenAI integrations to bring digital first care and research to everyone

Huma

Building and launching a scalable digital health product that meets regulatory demands typically takes a few years to deliver. Today, global healthcare AI company Huma Therapeutics Limited is announcing the completion of its Series D funding round to help cut that time down to days as it launches the Huma Cloud Platform. The platform offers no-code configuration of regulated disease management tools for any therapeutic area, a library of pre-built modules and device connectivity capabilities, a cloud-agnostic framework for flexible hosting, readily available APIs and integration capabilities, the ability to host and deploy diagnostic and predictive AI algorithms, a marketplace, and more to advance digital-first care and research. The Series D funding round, alongside investments from leading industry partners since its Series C round, created a total issuance of shares by Huma of over $80m. With this round, Huma has now raised over $300m. The Series D saw the participation of new and existing strategic and financial investors, including AstraZeneca, Hat Technology Fund 4 by HAT SGR, HV Fund by Hitachi Ventures and Leaps by Bayer and others. HSBC Bank plc acted as advisor to Huma during the fundraise. Alongside its Series D, Huma is also announcing the launch of its Huma Cloud Platform – a technology ecosystem designed not only to support the company’s own digital health initiatives, but also to empower others to launch and scale their projects efficiently. With its Huma Cloud Platform and the regulatory foundation that it is built on, Huma aims to reduce the time it takes to develop and launch digital health projects at scale from years to as little as a few days. The Huma Cloud Platform is built to serve the company's existing regulated products. In 2023, Huma achieved the landmark milestone of becoming the first and only configurable, disease-agnostic FDA Class II, EU MDR Class IIb, India CDSCO Class C and Saudi FDA Class C platform, enabling rapid, code-free configuration with the ability to host AI/ML models. The regulatory status of the Huma Cloud Platform significantly reduces the cost, time, and risks associated with bringing digital health projects to life. Huma is now making this platform available to customers which comes with a Software Development Kit (SDK) to enable the accelerated development of similar applications or to embed functionalities into their existing solutions. Dr Juergen Eckhardt, EVP, Head of Leaps by Bayer and Pharmaceuticals Business, Development & Licensing commented: “We have known Huma for several years and we've been impressed by their remarkable progress. We have seen this first-hand. They have demonstrated strong growth and excellent metrics. With their next-generation AI capabilities and Huma Cloud platform, Huma can partner with pharma companies to deliver efficient digital health solutions to patients focused on predictive and proactive care.” “Pharmaceutical companies need financially and technically efficient digital solutions to minimise spending on efforts that are duplicative or can't scale. The Huma Cloud Platform enables companies to streamline how they bring digital medicine, companion apps, and data collection capabilities to patients from the R&D phase to post-launch.” To date, Huma’s technology has powered projects in over 3,000 hospitals and clinics. The platform has been used to engage and screen over 35 million individuals, with 1.8 million active users across its products in over 70 countries. Huma’s U.S. business has grown significantly since launch with new reimbursement codes. The RPM product, built on top of the Huma Cloud Platform for respiratory use cases, now covers 140,000 contracted lives. As a result of all these successes, the company has doubled its revenue year-on-year, and is targeting to become profitable this year. Huma also collaborates with over half of the top 20 pharmaceutical companies globally and has been involved in major national healthcare projects worldwide. Huma has partnered with Google and others to develop new AI models that could enable its Cloud Platform users to care for many times more patients with less work; for example a feature called “10x Nurse” that significantly reduces administrative tasks and brings automation to the patient review process with a human in the loop. This opens new possibilities, such as efficiently managing chronic diseases with fewer staff or using real-time monitoring systems to ensure patients are on the correct treatment pathways while keeping humans still in the loop. Looking ahead, combining the Huma Cloud Platform with next-generation AI models will enable Huma to have a bigger impact through its digital-first care and research initiatives, as well as supporting small startups and enterprises in launching the digital solutions they need. It promises to do this much faster and cheaper, shifting the focus to project or venture success rather than getting distracted with scaling technology or managing regulatory burdens. Dan Vahdat, Founder and CEO of Huma, said, “I am thankful for the support of our new and existing shareholders, helping our vision become a reality, which we are closer to than ever before. We are here to accelerate the adoption of digital and AI across care and research, and we do that by making the building of digital health solutions for care and research easy. We like to think of Huma Cloud Platform much like Shopify but for digital health instead of e-commerce. We believe when digital and AI are scaled, they become affordable for both the poor and the rich. This will help us transition medicine from being reactive to proactive.” About Huma Huma is a global healthcare AI company on a mission to accelerate the adoption of digital solutions in care and research. Its award-winning modular platforms are used by more than 3,000 hospitals and clinics, with over 35 million screened users and 4 million registered users in healthcare, and has powered over 800 studies supporting about 1 million participants across research. The company is renowned for its role in major national healthcare projects worldwide, from the US and the UK to Germany, Greece, and Saudi Arabia, as well as collaborating with most large pharma companies. Huma's technology powers: ● multi-channel patient engagement at population-wide scale for healthcare systems ● remote patient monitoring (RPM) at scale ● companion apps to support patients through treatment and drug therapies ● digital clinical trials, including decentralised trials, to accelerate medical research Huma's regulated Software as a Medical Device, used in its RPM and companion app platforms, is the only disease- and device- agnostic platform to hold EU MDR Class IIb, US FDA (510-k) Class II clearance and Class IIb registration with the UK MHRA. The SaMD platform is regulated to accept artificial intelligence algorithms and monitor patients of all ages. For more information please visit www.huma.com. Contact Details Huma Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.huma.com/

July 16, 2024 08:00 AM Eastern Daylight Time

Image

Ultrahuman announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Ultrahuman

Ultrahuman, a pioneer in wearable technology, launches PowerPlugs, a platform for individual apps and plugins built on top of Ultrahuman’s health and wellness data stack. This is the world’s first in a smart ring form factor. Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals. At the forefront of PowerPlugs is AFib Detection, a PowerPlug that discreetly monitors your heart rhythm every night to detect signs of Atrial Fibrillation (AFib). Ultrahuman Ring AIR is the first smart ring in the world to offer AFib detection. AFib is the most common type of irregular heart rhythm or arrhythmia. It can lead to serious health complications such as stroke and heart failure, if left undetected. Individuals with potential arrhythmia episodes or a history of irregular rhythms can now track AFib closely and seek early intervention. Speaking on the launch, Mohit Kumar, Founder and CEO of Ultrahuman said “When it comes to health, one size doesn’t fit all. That’s why we built PowerPlugs for people to pick and choose what matters most for their health and wellness. Over the next few years, you could expect thousands of applications to be built on top of Ultrahuman’s comprehensive health data platform. Given our most comprehensive data stack of health markers from Ultrahuman Ring, M1 CGM, Ultrahuman Home and more to come, there’s infinite scope to build deep experiences over the next few years. Essentially, your Ultrahuman Ring will keep getting better after your purchase.” “We’re launching our first few PowerPlugs with a novel game changing capability, AFib detection. This life saving technology comes with medical approval in limited markets currently and we’re aggressively launching new markets with regulator’s approval every few weeks.” The PowerPlugs ecosystem can be accessed through the Ultrahuman App and is available in free and premium options. Circadian Rhythm Understanding the importance of aligning with natural circadian rhythms, the Ring AIR provides actionable recommendations tailored to your lifestyle. These suggestions include the optimal times to expose yourself to natural light, exercise, and wind down in the evening, aiming to enhance your energy levels, improve sleep quality, and bolster your overall health. Pregnancy Mode Pregnancy Mode adjusts health monitoring and recommendations specifically for pregnancy. It provides tailored advice on nutrition, activity levels, and health metrics that are crucial during this time. Gain insights into how to maintain your health and your baby's development, with safety and well-being as the priority. Cycle Tracking Cycle Tracking offers a comprehensive overview of your menstrual cycle phases and predicts upcoming cycles with high accuracy. This tool provides personalized insights into your fertility windows and symptom patterns, enabling proactive health management and lifestyle adjustments. Empower yourself with knowledge to make informed decisions about your reproductive health. Caffeine Window Track and optimize your consumption of stimulants such as caffeine throughout the day. By understanding your body's response to different stimulants, this tool advises on the best times for consumption to boost your alertness without affecting your nightly rest. Ideal for maintaining high energy levels and ensuring restful sleep. Vitamin D Manage Vitamin D intake through sun exposure. The app calculates the optimal times for you to step outside, based on your skin type, location, and current UV index, ensuring you get the most effective and safe sun exposure. It focuses on skin absorption, telling you precisely when to go out and estimating how much Vitamin D (in IU) your skin will absorb during your session. With real-time tracking and safety alerts to prevent overexposure, this PowerPlug makes maintaining healthy Vitamin D levels effortless and personalized. Jet Lag Jet Lag PowerPlug features personalized jet lag plans based on the users' travel itineraries, sleep patterns, and chronotypes, leveraging evidence-based methods involving light exposure, melatonin supplements, caffeine, and naps. It offers detailed schedules to follow before, during, and after trips, helping reset the circadian clock efficiently. Weight loss Integrate meal planning with real-time glucose monitoring to optimize your fitness journey. Ultrahuman Ring AIR tracks calories burnt throughout the day. It syncs with automated food logging to provide a comprehensive view of calorie intake versus expenditure. This helps users maintain a balanced diet and work towards their fitness goals without the hassle of manually logging their data. This is a game changer for anyone optimising their weight loss journey. Ovulation Women can now understand ovulation cycles, helping them better understand their bodies and menstrual health. For women looking to conceive, accurate ovulation detection can significantly increase the chances of pregnancy by identifying the most fertile days. Conversely, for those practising natural family planning methods, knowing the ovulation period can help in avoiding pregnancy. Additionally, continuous monitoring can help identify potential reproductive health issues early, allowing for timely interventions. Ultrahuman’s accessibility to health personalization doesn’t stop there. For the first time ever, developers can get access to Raw PPG, Accelerometer and Temperature data streams from the Ring AIR. Ultrahuman invites developers to build bespoke algorithms on top of these data streams from the Ring AIR using UltraSignal, Ultrahuman Ring AIR’s developer platform. UltraSignal will help fuel more customization and innovation in health. Developers can build custom algorithms for Sleep, Stress, Movement, Fertility and more, creating their own Powerplug. About Ultrahuman Ultrahuman is the world's most advanced metabolic fitness platform. Ultrahuman’s products include the Ultrahuman M1(continuous glucose monitoring sensor), the Ultrahuman Ring and Blood Vision, a preventive blood testing platform with the pioneering UltraTrace™ technology. By collating different biomarkers, Ultrahuman is helping people improve their energy levels and lifestyle, track their workout, sleep and recovery, and avoid metabolic disorders. For more information and updates on Ultrahuman, please visit ultrahuman.com or follow us on Facebook, Instagram, Twitter, LinkedIn, and YouTube. Contact Details Ultrahuman Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Ultrahuman Hisham Syed hisham@ultrahuman.com Company Website https://www.ultrahuman.com/

July 16, 2024 08:00 AM Eastern Daylight Time

Image

1 ... 83 84 85 86 87 ... 3736